Elucidating the integrative role and possible molecular mechanisms of Salvia miltiorrhiza ingredients and gut microbiota-derived metabolites in alleviating pyroptosis-mediated hepatic ischemia–reperfusion injury through network pharmacology

Currently, therapeutic options for hepatic ischemia–reperfusion injury (HIRI) remain limited and challenging. An emerging alternative involves the combination of ingredients from traditional Chinese medicine (TCM) and beneficial gut microbiota (GM) metabolites. This study integrates ingredients of S...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Rujia Wang, Danhong Yang, Yi Chen, Jiabing Wang
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Taylor & Francis Group 2025-12-01
Rangatū:	Artificial Cells, Nanomedicine, and Biotechnology
Ngā marau:	Hepatic ischemia–reperfusion injury Salvia miltiorrhiza gut microbiota network pharmacology miRNAs
Urunga tuihono:	https://www.tandfonline.com/doi/10.1080/21691401.2025.2547646
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!